Skip to main content
MEDIPOSTCO.,LTD. logo

MEDIPOSTCO.,LTD. — Investor Relations & Filings

Ticker · 078160 ISIN · KR7078160009 KO Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2025-12-16 Capital/Financing Update
Country KR South Korea
Listing KO 078160

About MEDIPOSTCO.,LTD.

https://en.medi-post.co.kr/

MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from MediPost, specifically detailing the issuance of convertible bonds (전환사채권 발행결정). It includes detailed terms of the bond, such as interest rates, conversion prices, maturity dates, and the use of proceeds for clinical trials. This falls under the category of capital and financing updates, as it describes a specific corporate financing activity involving the issuance of debt instruments convertible into equity.
2025-12-16 Korean
[기재정정]전환주식의전환청구권행사
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the exercise of conversion rights on convertible preferred shares into common shares, including specifics on share counts before and after conversion, capital changes, and the scheduled date for additional listing. It includes a correction notice about the change in the expected additional listing date. The content focuses on share capital changes due to conversion of preferred shares and related disclosures. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings. The document length is under 5,000 characters and is a regulatory announcement about capital changes, not a full report or financial statement.
2025-10-13 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled '임시주주총회결과' which translates to 'Extraordinary General Meeting (EGM) Results'. It details the resolutions passed at the meeting, including approval of amendments to the articles of incorporation and changes in business objectives. The document includes the date of the meeting and references related prior announcements. This matches the description of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document is short and focused on voting outcomes rather than the full meeting materials or presentations, so it is not AGM Information or Proxy Solicitation. Therefore, the correct classification is DVA with high confidence.
2025-10-13 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is titled '주식등의 대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding Status (General)'. It contains detailed information about shareholding quantities, ownership percentages, changes in shareholdings, and contractual relationships among shareholders. The document includes corrections to previously submitted large shareholding reports, detailed tables of share ownership by individuals and entities, and transaction details of shares. This type of document corresponds to notifications about major shareholding changes or holdings, which aligns with the category 'Major Shareholding Notification' (Code: MRQ). The document is not an annual report, earnings release, or any other financial report type, nor is it a simple announcement or certification. It is a detailed report on shareholding status and changes, fitting the MRQ category with high confidence.
2025-10-02 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is titled '주식등의 대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding Status (General)'. It includes detailed tables of shareholdings, changes in share numbers, ownership percentages, and contract details related to shareholding. The document also mentions corrections to a previously submitted report dated 2025-09-30. The content focuses on the disclosure of large shareholdings and changes thereof, which aligns with notifications of major shareholding changes. There is no indication that this is an annual report, earnings release, or other financial report. It is a detailed regulatory filing about share ownership levels crossing thresholds. Therefore, the document fits the category of Major Shareholding Notification (MRQ). The document length is substantial and contains detailed data, not just an announcement or certification, so it is not RNS or RPA. Confidence is high due to clear content and terminology.
2025-10-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a statutory report filed by a company’s major shareholder/executive (“임원ㆍ주요주주 특정증권등 소유상황보고서”) detailing the number of shares and changes in holdings, which corresponds to insider dealings by directors and executives. This matches the “Director’s Dealing” category.
2025-09-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.